Last Price$2.07Cboe Real-Time Last Sale as of 12:02PM ET 12/01/21
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.02(0.98%)
Bid (Size)$2.04 (100)
Ask (Size)$2.13 (100)
Day Low / High$2.02 - 2.10
Volume36.9 K

View Biotechnology IndustryPeer Comparison as of 12/01/2021


BioCardia Inc ( NASDAQ )

Price: $2.07
Change: +0.02 (0.98%)
Volume: 36.9 K
12:02PM ET 12/01/2021

Idera Pharmaceuticals Inc ( NASDAQ )

Price: $0.65
Change: -0.001 (0.15%)
Volume: 115.1 K
1:04PM ET 12/01/2021

ARCA Biopharma Inc ( NASDAQ )

Price: $2.30
Change: -0.07 (2.75%)
Volume: 386.4 K
1:07PM ET 12/01/2021

Brickell Biotech Inc ( NASDAQ )

Price: $0.31
Change: +0.004 (1.30%)
Volume: 1.8 M
1:10PM ET 12/01/2021

Zero Gravity Solutions Inc ( OTC )

Price: $0.90
Change: 0.00 (0.00%)
Volume: 20.00
12:25PM ET 8/18/2021

Read more news Recent News

-- Earnings Flash (BCDA) BIOCARDIA Reports Q3 Loss $-0.16
4:36PM ET 11/10/2021 MT Newswires


-- Earnings Flash (BCDA) BIOCARDIA Posts Q3 Revenue $821,000
4:30PM ET 11/10/2021 MT Newswires


Sector Update: Health Care Stocks Extending Retreat Ahead of Tuesday Close
3:57PM ET 10/12/2021 MT Newswires

Health care stocks were set to finish moderately lower this afternoon, with the NYSE Health Care Index falling 0.4% while the SPDR Health Care Select...

Sector Update: Health Care Stocks Falling Despite Moderate Rise Among Biotech Companies
1:12PM ET 10/12/2021 MT Newswires

Health care stocks were moderately lower this afternoon, with the NYSE Health Care Index falling 0.3%, while the SPDR Health Care Select Sector ETF (XLV)...

View all Commentary and Analysis

BioCardia, Inc. 2021 Q2 - Results - Earnings Call Presentation
4:35PM ET 8/13/2021 Seeking Alpha

Why I've Taken A Small Position In BioCardia
1:00PM ET 6/14/2021 Seeking Alpha

BioCardia Is Super Cheap With Multiple Shots On Goal
1:57PM ET 3/25/2021 Seeking Alpha

Longeveron Seeks $25 Million IPO For Anti-Aging Efforts
1:54PM ET 2/05/2021 Seeking Alpha

Company Profile

Business DescriptionBioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA. View company web site for more details
Address125 Shoreway Road
San Carlos, California 94070
Number of Employees27
President, Chief Executive Officer & DirectorPeter Alan Altman
Vice President-OperationsPhil Pesta
Chief Financial OfficerDavid McClung
Chief Scientific OfficerIan McNiece

Company Highlights

Price Open$2.00
Previous Close$2.05
52 Week Range$1.96 - 8.60
Market Capitalization$34.9 M
Shares Outstanding16.9 M
SectorHealth Technology
Next Earnings Announcement03/29/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.75
Beta vs. S&P 500N/A
Revenue$625.0 K
Net Profit Margin-1,237.37%
Return on Equity-72.74%

Analyst Ratings as of 10/01/2021

Consensus RecommendationConsensus Icon
Powered by Factset